S Hammerschmidt Selected Research

Immune Checkpoint Inhibitors

1/2022

Real-World Efficacy of Nintedanib Plus Docetaxel After Progression on Immune Checkpoint Inhibitors: Results From the Ongoing, Non-interventional VARGADO Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

S Hammerschmidt Research Topics

Disease

3	Lung Neoplasms (Lung Cancer) 05/2010 - 03/2006
3	Neoplasms (Cancer) 05/2010 - 12/2003
2	Chronic Obstructive Pulmonary Disease (COPD) 05/2010 - 01/2006
2	Inflammation (Inflammations) 05/2010 - 04/2004
2	Necrosis 11/2006 - 04/2004
2	Bronchitis 01/2006 - 05/2004
2	Infections 01/2006 - 02/2003
2	Acute Lung Injury 12/2002 - 04/2001
1	Nausea 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Adenocarcinoma 01/2022
1	Sepsis (Septicemia) 02/2010
1	Human Influenza (Influenza) 05/2008
1	Pneumothorax 09/2007
1	Emphysema 09/2007
1	Silicosis 03/2006
1	Pneumoconiosis 03/2006
1	Fibrosis (Cirrhosis) 03/2006
1	Malignant Pleural Effusion 02/2006
1	Cough 01/2006
1	Pharyngitis (Sore Throat) 01/2006
1	Pathologic Constriction (Stenosis) 08/2005
1	Diabetic Foot 05/2004
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2004
1	Pericardial Effusion 01/2004
1	Abdominal Pain (Pain, Abdominal) 01/2004
1	Pleural Solitary Fibrous Tumor 12/2003
1	Pneumococcal Infections 09/2001
1	Lung Injury 04/2001
1	Heart Failure 11/2000

Drug/Important Bio-Agent (IBA)

3	Anti-Bacterial Agents (Antibiotics)IBA 01/2006 - 02/2003
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2010 - 01/2007
2	Talc FDA Link 03/2006 - 02/2006
1	Docetaxel (Taxotere)FDA Link 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	nintedanibIBA 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2010
1	angiogeninIBA 05/2010
1	Interleukin-8 (Interleukin 8)IBA 05/2010
1	Proteins (Proteins, Gene)FDA Link 02/2010
1	Antirheumatic Agents (DMARD)IBA 11/2006
1	Tumor Necrosis Factor InhibitorsIBA 11/2006
1	AsbestosIBA 03/2006
1	Silicon Dioxide (Silica)FDA LinkGeneric 03/2006
1	QuartzIBA 03/2006
1	AluminumIBA 03/2006
1	Antitussive Agents (Antitussives)FDA Link 01/2006
1	NoxaeIBA 01/2006
1	Insulin (Novolin)FDA Link 05/2004
1	NitritesIBA 04/2004
1	Arginine (L-Arginine)FDA Link 04/2004
1	Captopril (Capoten)FDA LinkGeneric 04/2004
1	Cisplatin (Platino)FDA LinkGeneric 01/2004
1	Etoposide (VP 16)FDA LinkGeneric 01/2004
1	Carboplatin (JM8)FDA LinkGeneric 01/2004
1	Erythromycin (Erycette)FDA LinkGeneric 02/2003
1	dexpanthenol (panthenol)FDA Link 02/2003
1	Dexamethasone (Maxidex)FDA LinkGeneric 02/2003
1	Hypochlorous Acid (Hypochlorite)IBA 12/2002
1	AcidsIBA 12/2002
1	Fibronectins (Fibronectin)IBA 09/2001
1	Carrier Proteins (Binding Protein)IBA 09/2001
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 04/2001
1	Lipoxygenase InhibitorsIBA 04/2001
1	Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA 04/2001
1	EicosanoidsIBA 04/2001
1	Adrenergic Agents (Adrenergic Drugs)IBA 11/2000
1	IsoenzymesIBA 11/2000

Therapy/Procedure

5	Therapeutics 01/2022 - 05/2004
4	Drug Therapy (Chemotherapy) 01/2022 - 01/2004
1	Oral Hygiene (Dental Hygiene) 05/2008
1	Chest Tubes (Chest Tube) 09/2007
1	Pleurodesis 02/2006
1	Stents 08/2005
1	Radiotherapy 01/2004
1	Thoracotomy 12/2003